All In MedTech

Device type · JPH

Test, Erythrocyte Sedimentation Rate

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about JPH: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

JPH

Hematology

Device class

Class I

FDA decisions since 2015

0

510(k), De Novo and PMA

Adverse event reports

0

Received Nov 1, 2025 to Nov 20, 2026

How FDA classifies it

Device type
Test, Erythrocyte Sedimentation Rate
Product code
JPH
Device class
Class I
Review panel
Hematology
Regulation
21 CFR 864.6700

Latest FDA decisions

All decisions for JPH

No 510(k), De Novo or PMA decisions for this product code since 2015.

Reports received

0

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

0

Injury reports

0

Death reports

0

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor

No reports to chart for this view.

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

No manufacturers to rank.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

No device problems coded.

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

No patient problems coded.

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • POLYMEDCO, INC. / POLYMEDCO CANCER DIAGNOSTIC PRODUCTS, LLC

    Z-0107-2027 · Started Aug 25, 2026 · Posted by FDA Oct 7, 2026

    Reason given: During use of an affected tube, the operator may encounter increased resistance when inserting the pipette. The resulting pressure buildup may cause the tube cap to detach or be forcibly ejected, potentially resulting in the release of blood and exposure of the operator or surrounding work area to a biological hazard...

    Cause as FDA categorized it: Process control

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.